Publication
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Journal Paper/Review - Nov 17, 2021
Peyrin-Biroulet Laurent, Hart Ailsa, Bossuyt Peter, Long Millie, Allez Matthieu, Juillerat Pascal, Armuzzi Alessandro, Loftus Edward V, Ostad-Saffari Elham, Scalori Astrid, Oh Young S, Tole Swati, Chai Akiko, Pulley Jennifer, Lacey Stuart, Sandborn William J, HICKORY Study Group
Peyrin-Biroulet, Laurent
3
0
Hart, Ailsa
2
0
Bossuyt, Peter
1
0
Long, Millie
1
0
Allez, Matthieu
3
0
Juillerat, Pascal
13
0
Armuzzi, Alessandro
1
0
Loftus, Edward V
1
0
Ostad-Saffari, Elham
1
0
Scalori, Astrid
1
0
Oh, Young S
2
0
Tole, Swati
2
0
Chai, Akiko
2
0
Pulley, Jennifer
1
0
Lacey, Stuart
1
0
Sandborn, William J
1
0
HICKORY Study Group,
1
0